Lunesta vs. Sonata

See how Lunesta and Sonata compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Lunesta is approved for long-term, nightly insomnia treatment, while Sonata is approved only for short-term use, typically two to four weeks.

  • Both are Schedule IV controlled substances with FDA boxed warnings for complex sleep behaviors such as sleepwalking and sleep-driving.

  • Sonata's very short half-life means it can sometimes be taken in the middle of the night if at least four hours of sleep time remain, an option Lunesta does not offer.

Lunesta vs. Sonata Drug Summary

Lunesta

Lunesta (eszopiclone) is a nonbenzodiazepine hypnotic used to treat insomnia in adults. It is taken as an oral tablet once nightly and, unlike many sleep drugs, is approved for long-term nightly use. Its most distinctive side effect is a lingering unpleasant taste that affects a large share of users.

Sonata

Sonata (zaleplon) is a nonbenzodiazepine hypnotic used for the short-term treatment of insomnia in adults. It is taken as an oral capsule once nightly, and its very short half-life clears it from the body quickly. It is not approved for ongoing, nightly long-term use.

Lunesta vs. Sonata Side Effects

Lunesta

Most common
headache (up to 15%)
somnolence (up to 10%)
dizziness (up to 6%)
dysgeusia (up to 26%)

Sonata

Most common
headache (up to 28%)
somnolence (up to 5%)
dizziness (up to 7%)
nausea (up to 7%)

Lunesta vs. Sonata Dosage

Lunesta

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 3 mg once daily If needed
Dose changes 2 increases As tolerated

Sonata

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once nightly At the start
Maximum dose 20 mg once nightly If needed
Dose changes 2 increases As tolerated

Lunesta vs. Sonata Indications

Lunesta

Lunesta is FDA-approved for the treatment of insomnia in adults, with no set limit on how long it can be used. It works by slowing brain activity to help people fall asleep and stay asleep through the night. It has not been established as safe or effective in children.

  • Approved for adults with insomnia

  • Can be used for long-term nightly treatment

  • Taken as a tablet once daily at bedtime

  • Not approved for pediatric insomnia

Sonata

Sonata is FDA-approved for the short-term treatment of insomnia in adults, generally intended for use of two to four weeks. It works quickly because of its short half-life, making it well suited for people who have trouble falling asleep rather than staying asleep. It is not approved for long-term nightly use or for anyone under 18.

  • Approved for short-term insomnia in adults

  • Best suited for trouble falling asleep

  • Taken as a capsule once nightly

  • Not approved for long-term nightly use

Lunesta vs. Sonata Pros and Cons

Lunesta

Lunesta stands out for being approved for long-term, nightly use, making it suited for chronic insomnia rather than just occasional sleeplessness. Its longer duration of action can help with staying asleep, but it carries a distinctive unpleasant taste that affects many users. As a brand-name drug, its list price runs considerably higher than generic zaleplon.

Pros

  • Approved for long-term, nightly insomnia treatment

  • Longer duration of action can help with staying asleep

  • No middle-of-the-night sleep-window restriction like Sonata's

  • No tartrazine (Yellow No. 5) dye in the formulation

Cons

  • Signature unpleasant taste affects up to 26% of users

  • Costs roughly $1,300 to $1,600 per month, far more than generic zaleplon

  • Small risk of hallucinations, up to 2%

  • More CYP3A4 drug interactions than Sonata

Sonata

Sonata's very short half-life lowers the risk of next-morning grogginess if taken early enough in the night, and it produces fewer drug interactions since it bypasses CYP metabolism. It is approved only for short-term use, so it is not intended for ongoing nightly treatment. Generic zaleplon is inexpensive and widely available.

Pros

  • Generic zaleplon costs roughly $25 to $115 per month, far less than brand Lunesta

  • Very short half-life allows dosing mid-night if at least 4 hours of sleep remain

  • Fewer drug interactions due to non-CYP metabolism

  • Rapid onset suited to trouble falling asleep

Cons

  • Approved for short-term use only, not chronic nightly insomnia

  • Contains tartrazine (Yellow No. 5), a possible allergen

  • Highest reported side effect is headache, up to 28%

  • Short duration of action may not help with staying asleep all night

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.